GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), innovative technology for the analysis and purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in: • Basic R&D – Glycobiology & Glycoproteomics. • Biomarker Discover & Biomedical Diagnostics. • The Biopharmaceutical Industry. • Vaccines • Cosmetics GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant advantages over existing commercially available lectins products including: • Simplified, rapid & cost effective production through recombinant expression in Escherichia coli. • High purity & consistent performance. • Genetically enhanced glycan binding properties (specificity & affinity). • Scalable production facilitating utilization for large scale applications. For more information please visit our website at www.glycoselect.com